omaveloxolone

omaveloxolone
Trade Name
Orphan Indication Friedreich Ataxia
USA Market Approval USA
USA Designation Date 2017-06-19 00:00:00
Sponsor Reata Pharmaceuticals, Inc.;2801 Gateway Drive, Suite 150;Irving, Texas, 75063